Abstract
AimsSearching for EGFR and KRAS mutations within non-small cell lung carcinoma (NSCLC) samples remains time-consuming and can delay treatment choices in patients with acute deterioration. We evaluated the performances of...
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have